Royal Bank of Canada’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Buy |
5,145
+3,505
| +214% | +$8.86K | ﹤0.01% | 6032 |
|
|
2025
Q1 | $3K | Buy |
1,640
+478
| +41% | +$874 | ﹤0.01% | 6127 |
|
|
2024
Q4 | $3K | Sell |
1,162
-9,523
| -89% | -$24.6K | ﹤0.01% | 6165 |
|
|
2024
Q3 | $41K | Buy |
10,685
+4,547
| +74% | +$17.4K | ﹤0.01% | 5337 |
|
|
2024
Q2 | $31K | Buy |
6,138
+4,449
| +263% | +$22.5K | ﹤0.01% | 5485 |
|
|
2024
Q1 | $12K | Sell |
1,689
-10,484
| -86% | -$74.5K | ﹤0.01% | 5690 |
|
|
2023
Q4 | $109K | Buy |
12,173
+7,220
| +146% | +$64.7K | ﹤0.01% | 5039 |
|
|
2023
Q3 | $47K | Buy |
4,953
+1,374
| +38% | +$13K | ﹤0.01% | 5330 |
|
|
2023
Q2 | $53K | Buy |
3,579
+2,989
| +507% | +$44.3K | ﹤0.01% | 5309 |
|
|
2023
Q1 | $7K | Sell |
590
-957
| -62% | -$11.4K | ﹤0.01% | 6074 |
|
|
2022
Q4 | $28K | Buy |
+1,547
| New | +$28K | ﹤0.01% | 5694 |
|